• Intelligent Bio Solutions outlined its fingerprint-sweat drug screening system, targeting a 16–24 hour detection window to better indicate potential impairment.
• System workflow calls for 5-second fingertip collection, cartridge insertion into a reader, results in under 10 minutes; a faster cartridge study targets 70% quicker results.
• Company reported 480+ active accounts across 35 countries and territories; 1,800+ readers installed.
• Fiscal Q3 gross margin was 50.5%; Q3 revenue rose 46% year over year to $1.06 million; Q3 cartridge sales increased 59% to $703,538.
• Nine-month revenue increased 39% year over year to $3.07 million; manufacturing partnership targets over 40% annual production cost savings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief on July 21, 2026, and is solely responsible for the information contained therein.